The DOI matches its Crossref record; 205 of the 205 references it cites were found in a registry or an index.
Mesenchymal stem/stromal cells in cancer therapy
Open accessAbstract
The multipotent mesenchymal stem/stromal cells (MSCs), initially discovered from bone marrow in 1976, have been identified in nearly all tissues of human body now. The multipotency of MSCs allows them to give rise to osteocytes, chondrocytes, adipocytes, and other lineages. Moreover, armed with the immunomodulation capacity and tumor-homing property, MSCs are of special relevance for cell-based therapies in the treatment of cancer. However, hampered by lack of knowledge about the controversial roles that MSC plays in the crosstalk with tumors, limited progress has been made with regard to translational medicine. Therefore, in this review, we discuss the prospects of MSC-associated anticancer strategies in light of therapeutic mechanisms and signal transduction pathways. In addition, the clinical trials designed to appraise the efficacy and safety of MSC-based anticancer therapies will be assessed according to published data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The adaptability of MSCs, although beneficial in regenerative medicine, may elevate the risk of these cells unintentionally developing tumorigenic characteristics in the context of malignancy [300, 301].”
From Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword (2025) · cites this paper as [300]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A recent meta-analysis of MSC therapies in oncology revealed that modified MSCs may develop tumorigenic properties under prolonged culture conditions, especially with extensive passaging or exposure to pro-inflammatory cytokines.”
From Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword (2025) · cites this paper as [300]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies indicate that genetic modifications intended to enhance the regenerative potential of mesenchymal stem cells (MSCs), such as the overexpression of fibroblast growth factor-2 (FGF-2) or hepatocyte growth factor (HGF), may unintentionally promote tumor growth.”
From Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword (2025) · cites this paper as [300]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recent investigations have demonstrated that MSCs possess significant plasticity, enabling them to adapt dynamically to their microenvironment.”
From Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword (2025) · cites this paper as [300]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Studies indicate that MSCs derived from MM patients possess genetic mutations that increase their susceptibility to malignant transformation.”
From Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword (2025) · cites this paper as [300]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21654 · Cited by 16,522
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Human Adipose Tissue Is a Source of Multipotent Stem Cells
Zuk, P. A., Zhu, M., Ashjian, P. H., Ugarte, D. A. D., Huang, J. I., Mizuno, H., Alfonso, Z. C., Fraser, J. K., Benhaim, P., & Hedrick, M. H. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-02-0105 · Cited by 6,762
Role of YAP/TAZ in mechanotransduction
Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979
Stöckl, S., Göttl, C., Grifka, J. K., & Grässel, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350089 · Cited by 4,670
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“The tumor homing property of MSCs Since the development of cancer shares multiple similarities with wound healing, tumors are also known as “wounds that do not heal” [109].”
BackgroundMatrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Wnt signalling in stem cells and cancer
Reya, T., & Clevers, H. (2005) · Nature · doi:10.1038/nature03319 · Cited by 3,666
The complexity of NF-κB signaling in inflammation and cancer
Hoesel, B., & Schmid, J. A. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-86 · Cited by 3,277
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Sanchez-Vega, F., Mina, M., Armenia, J., Chatila, W. K., Luna, A., La, K. C., Dimitriadoy, S., Liu, D. L., Kantheti, H. S., Saghafinia, S., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.035 · Cited by 3,201
Multiple nuclear factors interact with the immunoglobulin enhancer sequences
Sen, R., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90346-6 · Cited by 2,754
Zhan, T., Rindtorff, N., & Boutros, M. (2017) · Oncogene · doi:10.1038/onc.2016.304 · Cited by 2,626
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Bartholomew, A. M., Sturgeon, C., Siatskas, M., Ferrer, K., McIntosh, K. R., Patil, S., Hardy, W., Devine, S. M., Ucker, D. S., Deans, R., et al. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(01)00769-x · Cited by 2,296
MECHANISMS OF WNT SIGNALING IN DEVELOPMENT
Wodarz, A., & Nusse, R. (1998) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.14.1.59 · Cited by 2,030
YAP/TAZ at the Roots of Cancer
Zanconato, F., Cordenonsi, M., & Piccolo, S. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.005 · Cited by 1,970
Huang, G. T. ‐., Gronthos, S., & Shi, S. (2009) · Journal of Dental Research · doi:10.1177/0022034509340867 · Cited by 1,924
The Hippo pathway and human cancer
Harvey, K. F., Zhang, X., & Thomas, D. M. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3458 · Cited by 1,867
PI3K pathway alterations in cancer: variations on a theme
Yuan, T. L., & Cantley, L. C. (2008) · Oncogene · doi:10.1038/onc.2008.245 · Cited by 1,845
Concise review: MSC-derived exosomes for cell-free therapy
Phinney, D. G., & Pittenger, M. F. (2017) · Stem Cells · doi:10.1002/stem.2575 · Cited by 1,834
Immunomodulatory properties of mesenchymal stromal cells
Nauta, A. J., & Fibbe, W. E. (2007) · Blood · doi:10.1182/blood-2007-02-069716 · Cited by 1,808
Human mesenchymal stem cells modulate B-cell functions
Corcione, A., Benvenuto, F., Ferretti, E., Giunti, D., Cappiello, V., Cazzanti, F., Risso, M., Gualandi, F., Mancardi, G. L., Pistoia, V., et al. (2006) · Blood · doi:10.1182/blood-2005-07-2657 · Cited by 1,767
ExoCarta: A Web-Based Compendium of Exosomal Cargo
Keerthikumar, S., Chisanga, D., Ariyaratne, D., Saffar, H. A., Anand, S., Zhao, K., Samuel, M., Pathan, M., Jois, M., Chilamkurti, N., et al. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.09.019 · Cited by 1,486
Jain, R. K., di Tomaso, E., Duda, D. G., Loeffler, J. S., Sorensen, A. G., & Batchelor, T. T. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2175 · Cited by 1,444
Role for Interferon-γ in the Immunomodulatory Activity of Human Bone Marrow Mesenchymal Stem Cells
Krampera, M., Cosmi, L., Angeli, R., Pasini, A., Liotta, F., Andreini, A., Santarlasci, V., Mazzinghi, B., Pizzolo, G., Vinante, F., et al. (2005) · Stem Cells · doi:10.1634/stemcells.2005-0008 · Cited by 1,311
PI3K-Akt pathway: Its functions and alterations in human cancer
Osaki, M., Oshimura, M., & Ito, H. (2004) · APOPTOSIS · doi:10.1023/b:appt.0000045801.15585.dd · Cited by 1,292
Wagner, W., Wein, F., Seckinger, A., Frankhauser, M., Wirkner, U., Krause, U., Blake, J., Schwager, C., Eckstein, V., Ansorge, W. J., et al. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2005.07.003 · Cited by 1,257
Gastric Cancer Originating from Bone Marrow-Derived Cells
Houghton, J., Stoicov, C., Nomura, S., Rogers, A. B., Carlson, J. E., Li, H., Cai, X., Fox, J. G., Goldenring, J. R., & Wang, T. C. (2004) · Science · doi:10.1126/science.1099513 · Cited by 1,174
Mesenchymal stem cells and immunomodulation: current status and future prospects
Gao, F., Chiu, S., Motan, D., Zhang, Z., Chen, L., Ji, H.-L., Tse, H.-F., Fu, Q.-L., & Lian, Q. (2016) · Cell Death and Disease · doi:10.1038/cddis.2015.327 · Cited by 1,154
Selmani, Z., Naji, A., Zidi, I., Favier, B., Gaiffe, É., Obert, L., Borg, C., Saas, P., Tiberghien, P., Rouas‐Freiss, N., et al. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0554 · Cited by 1,078
Spaggiari, G. M., Capobianco, A., Becchetti, S., Mingari, M. C., & Moretta, L. (2005) · Blood · doi:10.1182/blood-2005-07-2775 · Cited by 1,057
Schäffler, A., & Büchler, C. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0589 · Cited by 1,027
Concise Review: The Surface Markers and Identity of Human Mesenchymal Stem Cells
Lv, F., Tuan, R. S., Cheung, K., & Leung, V. (2014) · Stem Cells · doi:10.1002/stem.1681 · Cited by 980
Unravelling cancer stem cell potential
Beck, B., & Blanpain, C. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3597 · Cited by 915
(2002) · PubMed · Cited by 903
Pascucci, L., Coccè, V., Bonomi, A., Ami, D., Ceccarelli, P., Ciusani, E., Viganò, L., Locatelli, A., Sisto, F., Doglia, S. M., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.042 · Cited by 846
Miller, D. M., Thomas, S. D., Islam, A., Muench, D. E., & Sedoris, K. C. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0977 · Cited by 844
Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation
Anker, P. S. I. `., Scherjon, S. A., der Keur, C. K., Noort, W. A., Claas, F. H. J., Willemze, R., Fibbe, W. E., & Kanhai, H. H. H. (2003) · Blood · doi:10.1182/blood-2003-04-1291 · Cited by 807
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
Khakoo, A. Y., Pati, S., Anderson, S. A., Reid, W., Elshal, M. F., Rovira, I. I., Nguyen, A. T., Malide, D., Combs, C. A., Hall, G., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051921 · Cited by 747
Mesenchymal stem cell: An efficient mass producer of exosomes for drug delivery
Yeo, R. W. Y., Lai, R. C., Zhang, B., Tan, S. S., Yin, Y., Teh, B. J., & Lim, S. K. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.07.001 · Cited by 746
Devine, S. M., Cobbs, C., Jennings, M., Bartholomew, A. M., & Hoffman, R. (2003) · Blood · doi:10.1182/blood-2002-06-1830 · Cited by 740
Telomerase modulates Wnt signalling by association with target gene chromatin
Park, J.-I., Venteicher, A. S., Hong, J. Y., Choi, J., Jun, S., Shkreli, M., Chang, W., Meng, Z., Cheung, P., Ji, H., et al. (2009) · Nature · doi:10.1038/nature08137 · Cited by 707 · cited 1×
“Mechanistically, as a crucial signaling molecule in Wnt pathway, β-catenin improves the expression of telomerase reverse transcriptase (TERT), a ribonucleoprotein that prevents the loss of telomeres in cancer stem cells [79].”
BackgroundMyeloid Suppressor Lines Inhibit T Cell Responses by an NO-Dependent Mechanism
Mazzoni, A., Bronte, V., Visintin, A., Spitzer, J. H., Apolloni, E., Serafini, P., Zanovello, P., & Segal, D. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.689 · Cited by 692
Lee, J.-K., Park, S., Jung, B.-K., Jeon, Y., Lee, Y.-S., Kim, M.-K., Kim, Y.-G., Jang, J.-Y., & Kim, C.-W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084256 · Cited by 655
Biological functions of mesenchymal stem cells and clinical implications
Naji, A., Eitoku, M., Favier, B., Deschaseaux, F., Rouas‐Freiss, N., & Suganuma, N. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03125-1 · Cited by 649
Human Placenta‐Derived Cells Have Mesenchymal Stem/Progenitor Cell Potential
Fukuchi, Y., Nakajima, H., Sugiyama, D., Hirose, I., Kitamura, T., & Tsuji, K. (2004) · Stem Cells · doi:10.1634/stemcells.22-5-649 · Cited by 646
The CD95 (APO-1/Fas) and the TRAIL (APO-2L) Apoptosis Systems
Walczak, H., & Krammer, P. H. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4840 · Cited by 624
Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks
Liu, S., Ginestier, C., Ou, S. J., Clouthier, S. G., Patel, S. H., Monville, F., Korkaya, H., Heath, A., Dutcher, J., Kleer, C. G., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-0538 · Cited by 611
Role of PI3K/AKT pathway in cancer: the framework of malignant behavior
Jiang, N., Dai, Q., Su, X., Fu, J., Feng, X., & Peng, J. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05435-1 · Cited by 577
Roles for Growth Factors in Cancer Progression
Witsch, E., Sela, M., & Yarden, Y. (2010) · Physiology · doi:10.1152/physiol.00045.2009 · Cited by 568
Recent progress in the battle between oncolytic viruses and tumours
Parato, K. A., Senger, D. L., Forsyth, P. A., & Bell, J. C. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1750 · Cited by 555
Mesenchymal stem cells: key players in cancer progression
Ridge, S. M., Sullivan, F. J., & Glynn, S. A. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0597-8 · Cited by 526
Munoz, J. L., Bliss, S. A., Greco, S. J., Ramkissoon, S. H., Ligon, K. L., & Rameshwar, P. (2013) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.60 · Cited by 520
Mesenchymal stem cell-derived exosomes for clinical use
Mendt, M. C., Rezvani, K., & Shpall, E. J. (2019) · Bone Marrow Transplantation · doi:10.1038/s41409-019-0616-z · Cited by 472
Wnt/β-Catenin Signaling in Liver Development, Homeostasis, and Pathobiology
Russell, J. O., & Monga, S. P. (2018) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-044010 · Cited by 471
Ramasamy, R., Fazekasova, H., Lam, E. W. ‐., Soeiro, I., Lombardi, G., & Dazzi, F. (2007) · Transplantation · doi:10.1097/01.tp.0000244572.24780.54 · Cited by 468
Sources and Clinical Applications of Mesenchymal Stem Cells: State-of-the-art review
Berebichez‐Fridman, R., & Montero‐Olvera, P. R. (2018) · Sultan Qaboos University medical journal · doi:10.18295/squmj.2018.18.03.002 · Cited by 468
Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy?
Becker, A. D., & Riet, I. V. (2016) · World Journal of Stem Cells · doi:10.4252/wjsc.v8.i3.73 · Cited by 460
Ugarte, D. A. D., Alfonso, Z., Zuk, P. A., Elbarbary, A. S., Zhu, M., Ashjian, P. H., Benhaim, P., Hedrick, M. H., & Fraser, J. K. (2003) · Immunology Letters · doi:10.1016/s0165-2478(03)00108-1 · Cited by 458
Cancer-Associated Fibroblasts Build and Secure the Tumor Microenvironment
Liu, T., Zhou, L., Li, D., Andl, T., & Zhang, Y. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00060 · Cited by 446 · cited 1×
“Biological processes such as the growth of new blood vessels, activation of fibroblasts, remodeling of extracellular matrix (ECM) are associated with both tumor growth and wound healing [110].”
BackgroundMSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation
Kean, T. J., Lin, P. Y., Caplan, A. I., & Dennis, J. E. (2013) · Stem Cells International · doi:10.1155/2013/732742 · Cited by 442
Tondreau, T., Meuleman, N., Delforge, A., Dejeneffe, M., Leroy, R., Massy, M., Mortier, C., Bron, D., & Lagneaux, L. (2005) · Stem Cells · doi:10.1634/stemcells.2004-0330 · Cited by 438
Functional heterogeneity of mesenchymal stem cells: Implications for cell therapy
Phinney, D. G. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24166 · Cited by 437
Adipose Tissue–Derived Human Mesenchymal Stem Cells Mediated Prodrug Cancer Gene Therapy
Kucerova, L., Altanerova, V., Matuskova, M., Tyciakova, S., & Altaner, C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4024 · Cited by 431
Zhou, W., Zhou, Y., Chen, X., Ning, T., Chen, H., Guo, Q., Zhang, Y., Liu, P., Zhang, Y., Li, C., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120546 · Cited by 425
Mesenchymal Stem Cell Delivery of TRAIL Can Eliminate Metastatic Cancer
Loebinger, M. R., Eddaoudi, A., Davies, D., & Janes, S. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4698 · Cited by 417
Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc
Madden, S. K., de Araujo, A. D., Gerhardt, M., Fairlie, D. P., & Mason, J. M. (2021) · Molecular Cancer · doi:10.1186/s12943-020-01291-6 · Cited by 404
Mesenchymal Stem Cells Current Clinical Applications: A Systematic Review
Rodríguez-Fuentes, D. E., Fernández-Garza, L. E., Samia-Meza, J. A., Barrera-Barrera, S. A., Caplan, A. I., & Barrera-Saldaña, H. A. (2021) · Archives of Medical Research · doi:10.1016/j.arcmed.2020.08.006 · Cited by 376
Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells
Otsu, K., Das, S., Houser, S., Quadri, S. K., Bhattacharya, S., & Bhattacharya, J. (2008) · Blood · doi:10.1182/blood-2008-09-176198 · Cited by 348
Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1
Zhu, Y., Sun, Z., Han, Q., Liao, L., Wang, J., Bian, C., Li, J., Yan, X., Liu, Y., Shao, C., et al. (2009) · Leukemia · doi:10.1038/leu.2008.384 · Cited by 347
Therapeutic Potential of Mesenchymal Stem Cells for Cancer Therapy
Hmadcha, A., Martín‐Montalvo, A., Gauthier, B. R., Soria, B., & Capilla‐González, V. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00043 · Cited by 346
Bone marrow-derived mesenchymal stem cells and the tumor microenvironment
Bergfeld, S. A., & DeClerck, Y. A. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9222-7 · Cited by 345
Shi, M., Li, J., Liao, L., Chen, B., Li, B., Chen, L., Jia, H., & Zhao, R. C. H. (2007) · Haematologica · doi:10.3324/haematol.10669 · Cited by 341
Markers Distinguishing Mesenchymal Stem Cells from Fibroblasts Are Downregulated with Passaging
Halfon, S., Abramov, N., Grinblat, B., & Ginis, I. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0040 · Cited by 327
Advances in mesenchymal stem cell exosomes: a review
Tang, Y., Zhou, Y., & Li, H.-J. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02138-7 · Cited by 327
Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition
Groner, B., & von Manstein, V. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.05.033 · Cited by 308
IL-12 Family Cytokines in Cancer and Immunotherapy
Mirlekar, B., & Pylayeva‐Gupta, Y. (2021) · Cancers · doi:10.3390/cancers13020167 · Cited by 307
Analysis of the role of the Hippo pathway in cancer
Han, Y. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1869-4 · Cited by 298
Mesenchymal stem cell-based drug delivery strategy: from cells to biomimetic
Wu, H., Zhou, Y., Tabata, Y., & Gao, J. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.019 · Cited by 296
PI3K and AKT: Unfaithful Partners in Cancer
Faes, S., & Dormond, O. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160921138 · Cited by 279
Mechanisms of Regulation of the Chemokine-Receptor Network
Stone, M. J., Hayward, J. A., Huang, C., Huma, Z. E., & Sanchez, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020342 · Cited by 277
Targeting the Tumor Microenvironment with Interferon-β Bridges Innate and Adaptive Immune Responses
Yang, X., Zhang, X., Fu, M. L., Weichselbaum, R. R., Gajewski, T. F., Guo, Y., & Fu, Y. (2014) · Cancer Cell · doi:10.1016/j.ccr.2013.12.004 · Cited by 274
Stromal cell-derived factor-1 (SDF-1): homing factor for engineered regenerative medicine
Lau, T. T., & Wang, D. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.546338 · Cited by 273
DelaRosa, O., Lombardo, E., Beraza, A., Mancheño‐Corvo, P., Ramirez, C., Menta, R., Rico, L., Camarillo‐Retamosa, E., García‐García, L., Abad, J. L., et al. (2009) · Tissue Engineering Part A · doi:10.1089/ten.tea.2008.0630 · Cited by 271
Emerging Prospects of Exosomes for Cancer Treatment: From Conventional Therapy to Immunotherapy
Nam, G., Choi, Y., Kim, G. B., Kim, S., Kim, S. A., & Kim, I. (2020) · Advanced Materials · doi:10.1002/adma.202002440 · Cited by 270
Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells
Gieseke, F., Böhringer, J., Bussolari, R., Dominici, M., Handgretinger, R., & Müller, I. (2010) · Blood · doi:10.1182/blood-2010-02-270777 · Cited by 269
Beyond IκBs: alternative regulation of NF‐KB activity
Neumann, M., & Naumann, M. (2007) · The FASEB Journal · doi:10.1096/fj.06-7615rev · Cited by 267
Ekström, E. J., Bergenfelz, C., von Bülow, V., Serifler, F., Carlemalm, E., Jönsson, G., Andersson, T., & Leandersson, K. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-88 · Cited by 262
Wnt secretion is required to maintain high levels of Wnt activity in colon cancer cells
Voloshanenko, O., Erdmann, G., Dubash, T. D., Augustin, I., Metzig, M. O., Moffa, G., Hundsrucker, C., Kerr, G., Sandmann, T., Anchang, B., et al. (2013) · Nature Communications · doi:10.1038/ncomms3610 · Cited by 257
Chronic graft-versus-host disease: clinical manifestation and therapy
Ratanatharathorn, V., Ayash, L. J., Lazarus, H. M., Fu, J., & Uberti, J. P. (2001) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703111 · Cited by 256
Chawla‐Sarkar, M., Leaman, D. W., & Borden, E. C. (2001) · PubMed · Cited by 249
The roles of mesenchymal stem cells in tumor inflammatory microenvironment
Sun, Z., Wang, S., & Zhao, R. C. (2014) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-7-14 · Cited by 249
Chaturvedi, P., Gilkes, D. M., Wong, C. C., Gupta, K., Luo, W., Zhang, H., Wei, H., Takano, N., Schito, L., Levchenko, A., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64993 · Cited by 245
Zhang, T., Lee, W., Rui, Y., Cheng, T.-Y., Jiang, X., & Li, G. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt221 · Cited by 244
Elbadawy, M., Usui, T., Yamawaki, H., & Sasaki, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092340 · Cited by 243
Zhang, X., Hu, F., Li, G., Li, G., Yang, X., Liu, L., Zhang, R., Zhang, B., & Feng, Y. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0176-3 · Cited by 243
Ho, I. A. W., Toh, H. C., Ng, W. H., Teo, Y. L., Guo, C. M., Hui, K. M., & Lam, P. Y. P. (2012) · Stem Cells · doi:10.1002/stem.1247 · Cited by 241
Yong, R. L. M., Shinojima, N., Fueyo-Margareto, J., Gumin, J., Vecil, G. G., Marini, F. C., Bögler, O., Andreeff, M., & Lang, F. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3873 · Cited by 239
Barcellos‐de‐Souza, P., Comito, G., Segura, C. P., Taddei, M. L., Gori, V., Becherucci, V., Bambi, F., Margheri, F., Laurenzana, A., Rosso, M. D., et al. (2016) · Stem Cells · doi:10.1002/stem.2412 · Cited by 236
Valera, A., López‐Guillermo, A., Cardesa‐Salzmann, T. M., Climent, F., González-Barca, E. M., Mercadal, S., Espinosa, Í., Novelli, S., Briones, J., Mate, J. L., et al. (2013) · Haematologica · doi:10.3324/haematol.2013.086173 · Cited by 230
Bozorgmehr, M., Gurung, S., Darzi, S., Nikoo, S., Kazemnejad, S., Zarnani, A., & Gargett, C. E. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00497 · Cited by 225
Mesenchymal Stem Cells Home to Sites of Injury and Inflammation
Rustad, K. C., & Gurtner, G. C. (2012) · Advances in Wound Care · doi:10.1089/wound.2011.0314 · Cited by 221
Production of mesenchymal stromal/stem cells according to good manufacturing practices: a review
Sensebé, L., Gadelorge, M., & Fleury‐Cappellesso, S. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt217 · Cited by 209
Stoff‐Khalili, M. A., Rivera, Á. A., Mathis, J. M., Banerjee, N. S., Moon, A. S., Hess, A., Rocconi, R. P., Numnum, T. M., Everts, M., Chow, L. T., et al. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9449-8 · Cited by 205
Stem cells in cancer therapy: opportunities and challenges
Zhang, C.-L., Huang, T., Wu, B.-L., He, W., & Liu, D. (2017) · Oncotarget · doi:10.18632/oncotarget.20798 · Cited by 204
Teo, G. S. L., Ankrum, J. A., Martinelli, R., Boetto, S. E., Simms, K., Sciuto, T. E., Dvořàk, A. M., Karp, J. M., & Carman, C. V. (2012) · Stem Cells · doi:10.1002/stem.1198 · Cited by 201
Baglioni, S., Francalanci, M., Squecco, R., Lombardi, A., Cantini, G., Angeli, R., Gelmini, S., Guasti, D., Benvenuti, S., Annunziato, F., et al. (2009) · The FASEB Journal · doi:10.1096/fj.08-126946 · Cited by 194
Cavarretta, I. T. R., Altanerová, V., Matúšková, M., Kučerová, L., Čulig, Z., & Altaner, Č. (2009) · Molecular Therapy · doi:10.1038/mt.2009.237 · Cited by 189
Interaction of MSC with tumor cells
Melzer, C., Yang, Y., & Hass, R. (2016) · Cell Communication and Signaling · doi:10.1186/s12964-016-0143-0 · Cited by 189
Functions and application of exosomes.
Qin, J., & Xu, Q. R. (2014) · PubMed · Cited by 182
Kucerova, L., Matuskova, M., Pastorakova, A., Tyciakova, S., Jakubikova, J., Bohovic, R., Altanerova, V., & Altaner, C. (2008) · The Journal of Gene Medicine · doi:10.1002/jgm.1239 · Cited by 171
Mesenchymal Stem Cells and Cancer: Clinical Challenges and Opportunities
Lin, W., Huang, L., Li, Y., Fang, B., Li, G., Chen, L., & Xu, L. (2019) · BioMed Research International · doi:10.1155/2019/2820853 · Cited by 168
Galland, S., & Stamenkovic, I. (2020) · The Journal of Pathology · doi:10.1002/path.5357 · Cited by 165
Bouchekioua, A., Scourzic, L., Wever, O. D., Zhang, Y., Cervera, P., Aline-Fardin, A., Mercher, T., Gaulard, P., Nyga, R., Jeziorowska, D., et al. (2013) · Leukemia · doi:10.1038/leu.2013.157 · Cited by 161
Gao, P., Ding, Q., Wu, Z., Jiang, H., & Fang, Z. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.08.031 · Cited by 161
Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells
Kanehira, M., Xin, H., Hoshino, K., Maemondo, M., Mizuguchi, H., Hayakawa, T., Matsumoto, K., Nakamura, T., Nukiwa, T., & Saijo, Y. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701079 · Cited by 156
NK4 (HGF‐antagonist/angiogenesis inhibitor) in cancer biology and therapeutics
Matsumoto, K., & Nakamura, T. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01440.x · Cited by 153
Secchiero, P., Zorzet, S., Tripodo, C., Corallini, F., Melloni, E., Caruso, L., Bosco, R., Ingrao, S., Zavan, B., & Zauli, G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011140 · Cited by 153
YAP is a critical oncogene in human cholangiocarcinoma
Pei, T., Li, Y., Wang, J., Wang, H., Liang, Y., Shi, H., Sun, B., Yin, D., Sun, J., Song, R., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4043 · Cited by 151
Bone marrow transplantation: a review.
Thomas, E. D. (1999) · PubMed · Cited by 150
Seo, S. H., Kim, K. S., Park, S. H., Suh, Y. S., Kim, S. J., Jeun, S.-S., & Sung, Y. C. (2011) · Gene Therapy · doi:10.1038/gt.2010.170 · Cited by 148
Yan, X., Fu, C., Chen, L., Qin, J., Zeng, Q., Yuan, H., Nan, X., Chen, H., Zhou, J., Lin, Y.-L., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1577-0 · Cited by 145
The regulation and function of YAP transcription co-activator
Zhu, C., Li, L., & Zhao, B. (2014) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmu110 · Cited by 143
Altaner, Č. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.04.023 · Cited by 138
Avnet, S., Pompo, G. D., Chano, T., Errani, C., Ibrahim‐Hashim, A., Gillies, R. J., Donati, D. M., & Baldini, N. (2016) · International Journal of Cancer · doi:10.1002/ijc.30540 · Cited by 138
Danks, M. K., Yoon, K. J., Bush, R. A., Remack, J. S., Wierdl, M., Tsurkan, L. G., Kim, S. U., Garcia, E. P., Metz, M. Z., Najbauer, J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3607 · Cited by 136
Differentiation potential of stem cells from human dental origin - promise for tissue engineering.
Kádár, K., Király, M., Porcsalmy, B., Molnár, B., Rácz, G., Blazsek, J., Kálló, K., Szabo, E. L., Gera, I., Gerber, G., et al. (2009) · PubMed · Cited by 135
PEX-Producing Human Neural Stem Cells Inhibit Tumor Growth in a Mouse Glioma Model
Kim, S., Cargioli, T. G., Machluf, M., Yang, W., Sun, Y., Al-Hashem, R., Kim, S. U., Black, P. M., & Carroll, R. S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0371 · Cited by 134
Mechanisms of tumor escape from immune system: Role of mesenchymal stromal cells
Poggi, A. D., Musso, A., Dapino, I., & Zocchi, M. R. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.03.001 · Cited by 126
Evolution of Cytokine Receptor Signaling
Liongue, C., Sertori, R., & Ward, A. C. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600372 · Cited by 117
Nieß, H., von Einem, J. C., Thomas, M. N., Michl, M., Angele, M. K., Huss, R., Günther, C., Nelson, P. J., Bruns, C. J., & Heinemann, V. (2015) · BMC Cancer · doi:10.1186/s12885-015-1241-x · Cited by 116
Role of MSC in the Tumor Microenvironment
Hass, R. (2020) · Cancers · doi:10.3390/cancers12082107 · Cited by 116
Riekstiņa, U., Muceniece, R., Čakstiņa, I., Muižnieks, I., & Ancāns, J. (2008) · Cytotechnology · doi:10.1007/s10616-009-9183-2 · Cited by 115
Schüring, A. N., Schulte, N., Kelsch, R., Röpke, A., Kiesel, L., & Götte, M. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.08.035 · Cited by 109
Zhou, J., Tan, X., Tan, Y., Li, Q., Ma, J., & Wang, G. (2018) · Journal of Cancer · doi:10.7150/jca.25376 · Cited by 109
Mechanoresponsive stem cells to target cancer metastases through biophysical cues
Liu, L., Zhang, S. X., Liao, W., Farhoodi, H. P., Wong, C. W., Chen, C. C., Ségaliny, A. I., Chacko, J. V., Nguyen, L., Lu, M., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan2966 · Cited by 104
Power, A., & Bell, J. C. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300098 · Cited by 103
He, N., Kong, Y., Lei, X., Liu, Y., Wang, J., Xu, C., Wang, Y., Du, L., Ji, K., wang, Q., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0949-3 · Cited by 103
Gong, A., Wei, P. Y., Zhang, S., Yao, J., Yuan, Y., Zhou, A., Lang, F. F., Heimberger, A. B., Rao, G., & Huang, S. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2800 · Cited by 102
Mesenchymal stem cell signaling in cancer progression
Torsvik, A., & Bjerkvig, R. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.03.005 · Cited by 100
Isolation, Characterization, Differentiation, and Application of Adipose-Derived Stem Cells
Kuhbier, J. W., Weyand, B., Radtke, C., Vogt, P. M., Kasper, C., & Reimers, K. (2010) · Springer eBooks · doi:10.1007/10_2009_24 · Cited by 99
Mamidi, M. K., Nathan, K. G., Singh, G., Thrichelvam, S. T., Yusof, N. A. N. M., Fakharuzi, N. A., Zakaria, Z., Bhonde, R. R., Das, A. K., & Majumdar, A. S. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24193 · Cited by 98
Mueller, L. P., Luetzkendorf, J., Widder, M., Nerger, K., Caysa, H., & Mueller, T. (2010) · Cancer Gene Therapy · doi:10.1038/cgt.2010.68 · Cited by 98
Schweizer, M. T., Wang, H., Bivalacqua, T. J., Partin, A. W., Lim, S. J., Chapman, C. G., Abdallah, R. H., Levy, O., Bhowmick, N. A., Karp, J. M., et al. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.18-0230 · Cited by 98
Mesenchymal Stem/Stromal Cell Engulfment Reveals Metastatic Advantage in Breast Cancer
Chen, Y., González, M. E., Burman, B., Zhao, X., Anwar, T., Tran, M., Medhora, N., Hiziroglu, A. B., Lee, W., Cheng, Y.-H., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.084 · Cited by 97
von Einem, J. C., Guenther, C., Volk, H., Grütz, G., Hirsch, D. D., Salat, C., Stoetzer, O. J., Nelson, P. J., Michl, M., Modest, D. P., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32230 · Cited by 93
Yoon, A. R., Hong, J., Li, Y., Shin, H. C., Lee, H., Kim, H., & Yun, C. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3900 · Cited by 93
Wang, W., Zhong, W., Yuan, J., Yan, C., Hu, S., Tong, Y., Mao, Y., Hu, T., Zhang, B., & Song, G. (2015) · Oncotarget · doi:10.18632/oncotarget.5514 · Cited by 92
c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia
Xia, B., Tian, C., Guo, S., Zhang, L., Zhao, D., Qu, F., Zhao, W., Wang, Y., Wu, X., Da, W.-M., et al. (2014) · Leukemia Research · doi:10.1016/j.leukres.2014.11.004 · Cited by 86
NF-κB Activity Regulates Mesenchymal Stem Cell Accumulation at Tumor Sites
Uchibori, R., Tsukahara, T., Mizuguchi, H., Saga, Y., Urabe, M., Mizukami, H., Kume, A., & Ozawa, K. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0088 · Cited by 83
Lü, L., Chen, G., Yang, J., Ma, Z., Yang, Y., Hu, Y., Lu, Y., Cao, Z., Wang, Y., & Wang, X. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108625 · Cited by 82
Liu, Y., Ren, H., Zhou, Y., Shang, L., Zhang, Y., Yang, F., & Shi, X. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1219-7 · Cited by 82
Hippo pathway - brief overview of its relevance in cancer.
Zygulska, A. L., Krzemieniecki, K., & Pierzchalski, P. (2017) · PubMed · Cited by 82
Both human and mouse mesenchymal stem cells promote breast cancer metastasis
Albarenque, S. M., Zwacka, R. M., & Mohr, A. (2011) · Stem Cell Research · doi:10.1016/j.scr.2011.05.002 · Cited by 80
Bajetto, A., Pattarozzi, A., Corsaro, A., Barbieri, F., Daga, A., Bosio, A. G., Gatti, M., Pisaturo, V., Sirito, R., & Florio, T. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00312 · Cited by 80
Expression of hippo pathway in colorectal cancer
Zhang, C., Liang, K., Zhou, G., Zhang, Q., & Li, J. (2014) · Saudi Journal of Gastroenterology · doi:10.4103/1319-3767.133025 · Cited by 80
Wu, X., Liu, Y., Wang, G., Xu, X., Cai, Y., Wang, H., Li, Y., Meng, H., Dai, F., & Jin, J.-D. (2016) · Scientific Reports · doi:10.1038/srep21420 · Cited by 79
Raynaud, C. M., Maleki, M., Lis, R., Ahmed, B., Al-Azwani, I. K., Malek, J. A., Safadi, F. F., & Rafii, A. (2012) · Stem Cells International · doi:10.1155/2012/658356 · Cited by 77
Fathi, E., Sanaat, Z., & Farahzadi, R. (2019) · Blood Research · doi:10.5045/br.2019.54.3.165 · Cited by 76
Luo, T., Liu, Q., Tan, A., Duan, L., Jia, Y., Li, N., Tang, J. Y., Zhou, W., Xie, W., Lu, Y., et al. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.10.008 · Cited by 74
Mele, V., Muraro, M. G., Calabrese, D., Pfaff, D., Amatruda, N., Amicarella, F., Kvinlaug, B. T., Bocelli‐Tyndall, C., Martín, I., Resink, T. J., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28598 · Cited by 73
Human stem cells expressing novel TSP-1 variant have anti-angiogenic effect on brain tumors
van Eekelen, M., Sasportas, L. S., Kasmieh, R., Yip, S. S. F., Figueiredo, J.-L., Louis, D. N., Weissleder, R., & Shah, K. (2010) · Oncogene · doi:10.1038/onc.2010.75 · Cited by 72
Mesenchymal stem cells and cancer therapy: insights into targeting the tumour vasculature
Surendar, A., Ejam, S. S., Lafta, M. H., Markov, A. A., Yumashev, A. V., & Ahmadi, M. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01836-9 · Cited by 71
Directing systemic oncolytic viral delivery to tumors via carrier cells☆
Nakashima, H., Kaur, B., & Chiocca, E. A. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.02.004 · Cited by 69
Liu, C., Feng, X., Wang, B., Wang, X., Wang, C., Yu, M., Cao, G., & Wang, H. (2017) · Cancer Science · doi:10.1111/cas.13479 · Cited by 68
Cytokine gene therapy for malignant glioma
Okada, H., & Pollack, I. F. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.10.1609 · Cited by 64
MSC and Tumors: Homing, Differentiation, and Secretion Influence Therapeutic Potential
D’souza, N., Burns, J. S., Grisendi, G., Candini, O., Veronesi, E., Piccinno, M. S., Horwitz, E. M., Paolucci, P., Conte, P., & Dominici, M. (2012) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2012_150 · Cited by 63
Li, J., Deng, Z., Wang, Z., Wang, D., Zhang, L., Su, Q., Lai, Y., Ли, Б., Luo, Z., Xu, C., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3200 · Cited by 62
Fernández-García, M., Yañez, R. M., Sánchez‐Domínguez, R., Hernando-Rodríguez, M., Peces-Barba, M., Herrera, G., O’Connor, J., Segovia, J. C., Bueren, J. A., & Lamana, M. L. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0155-5 · Cited by 62
Wan, C., He, Q., McCaigue, M. D., Marsh, D., & Li, G. (2005) · Journal of Orthopaedic Research® · doi:10.1002/jor.20023 · Cited by 62
Maffey, A., Storini, C., Diceglie, C., Martelli, C., Sironi, L., Calzarossa, C., Tonna, N., Lovchik, R. D., Delamarche, E., Ottobrini, L., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13460-7 · Cited by 60
Zhang, L., Wang, W., Wang, R., Zhang, N., Shang, H., Bi, Y., Chen, D., Zhang, C., Li, L., Yin, J., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.10.027 · Cited by 58
Zhong, W., Tong, Y., Li, Y., Yuan, J., Hu, S., Hu, T., & Song, G. (2017) · Oncotarget · doi:10.18632/oncotarget.17793 · Cited by 56
Expansion of cancer stem cell pool initiates lung cancer recurrence before angiogenesis
Li, L., Li, J.-C., Yang, H., Zhang, X., Liu, L., Li, Y., Zeng, T., Zhu, Y.-H., Li, X.-D., Li, Y., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806219115 · Cited by 53
Mechanisms of measles virus oncolytic immunotherapy
Pidelaserra-Martí, G., & Engeland, C. E. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.07.009 · Cited by 53
McGuire, J., Frieling, J. S., Lo, C. H., Li, T., Muhammad, A., Lawrence, H. R., Lawrence, N. J., Cook, L. M., & Lynch, C. C. (2021) · Nature Communications · doi:10.1038/s41467-021-20962-6 · Cited by 52
Raicevic, G., Najar, M., Najimi, M., Taghdouini, A. E., van Grunsven, L. A., Sokal, E. M., & Toungouz, M. (2014) · Cytotherapy · doi:10.1016/j.jcyt.2014.10.001 · Cited by 51
Thrombospondin-1 promotes mesenchymal stromal cell functions via TGFβ and in cooperation with PDGF
Belotti, D., Capelli, C., Resovi, A., Introna, M., & Taraboletti, G. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.03.003 · Cited by 50
Liu, Y., Ren, H., Wang, J., Yang, F., Li, J., Zhou, Y., Yuan, X., Zhu, W., & Shi, X. (2018) · The FASEB Journal · doi:10.1096/fj.201801349rr · Cited by 50
Characterization of Mononucleated Human Peripheral Blood Cells
Kadir, R. A., Ariffin, S. H. Z., Wahab, R. M. A., Kermani, S., & Senafi, S. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/843843 · Cited by 48
Salha, S., Gehmert, S., Brébant, V., Anker, A., Loibl, M., Prantl, L., & Gehmert, S. (2018) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-189319 · Cited by 48
Mesenchymal Stem Cells: Characteristics, Function, and Application
Li, Z., Hu, X., & Zhong, J. F. (2019) · Stem Cells International · doi:10.1155/2019/8106818 · Cited by 48
The response of human ectomesenchymal dental pulp stem cells to cisplatin treatment
Seifrtová, M., Havelek, R., Ćmielová, J., Jiroutová, A., Soukup, T., Brůčková, L., Mokrý, J., English, D. K., & Řezáčová, M. (2011) · International Endodontic Journal · doi:10.1111/j.1365-2591.2011.01990.x · Cited by 44
Mirtti, T. K., Leiby, B. E., Abdulghani, J., Aaltonen, E., Pavela, M., Mamtani, A., Alanen, K. A., Egevad, L., Granfors, T., Josefsson, A., et al. (2012) · Human Pathology · doi:10.1016/j.humpath.2012.06.001 · Cited by 44
Chen, H., Mei, L., Zhou, L., Shen, X., Guo, C., Zheng, Y., Zhu, H., Zhu, Y., & Huang, L. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0492-2 · Cited by 43
Mesenchymal stem cells for graft-versus-host disease: a double edged sword?
Vianello, F., & Dazzi, F. (2008) · Leukemia · doi:10.1038/leu.2008.25 · Cited by 39
Yang, P., Hsieh, Y., Du, J.-L., Yen, S.-C., & Hung, C. (2020) · Biomolecules · doi:10.3390/biom10040643 · Cited by 36
Growth‐inhibitory activity of interferon‐beta against human colorectal carcinoma cell lines
Wong, V. L. Y., Rieman, D. J., Aronson, L., Dalton, B. J., GREIG, R. G., & Anzano, M. A. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910430331 · Cited by 35
Mesenchymal Stem Cells in Gastric Cancer: Vicious but Hopeful
Li, Y., Zhong, X., Zhang, Y., & Lu, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.617677 · Cited by 34
Dührsen, L., Hartfuß, S., Hirsch, D. D., Geiger, S., Maire, C. L., Sedlacik, J., Guenther, C., Westphal, M., Lamszus, K., Hermann, F. G., et al. (2019) · Oncotarget · doi:10.18632/oncotarget.27071 · Cited by 34
Liu, D., Shen, X., Zhu, G., & Xing, M. (2015) · Oncotarget · doi:10.18632/oncotarget.5391 · Cited by 33
Can neural stem cells be used as therapeutic vehicles in the treatment of brain tumors?
Noble, M. (2000) · Nature Medicine · doi:10.1038/74610 · Cited by 33
Sarmadi, V. H., Tong, C. K., Vidyadaran, S., Abdullah, M., Seow, H. F., & Ramasamy, R. (2010) · PubMed · Cited by 28
Role of MSC-derived galectin 3 in the AML microenvironment
Ruvolo, P. P., Ruvolo, V. R., Burks, J. K., Qiu, Y., Wang, R., Shpall, E. J., Mirandola, L., Hail, N., Zeng, Z., McQueen, T. J., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.04.005 · Cited by 26
Ai, J., Ketabchi, N., Verdi, J., Gheibi, N., Haghighian, H. K., & Kavianpour, M. (2019) · Cancer Cell International · doi:10.1186/s12935-019-1038-0 · Cited by 26
[Study on culture and in vitro osteogenesis of blood-derived human mesenchymal stem cells].
Cao, C., Dong, Y., & Dong, Y. (2005) · PubMed · Cited by 26
Human Bone Marrow Mesenchymal Stem Cells Promote Gastric Cancer Growth via Regulating c-Myc
Chen, B., Yu, J. Q., Wang, Q., Zhao, Y., Sun, L., Xu, C., Zhao, X., Shen, B., Wang, M., Xu, W., et al. (2018) · Stem Cells International · doi:10.1155/2018/9501747 · Cited by 26
MYC modulators in cancer: a patent review
Wang, X., Su, X., Cheng, S.-Q., Zhi-yin, S., Huang, Z., & Ou, T. (2019) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2019.1612878 · Cited by 25
Research works printed but not linked: 2
- Khakoo AY, Pati S, Anderson SA, Reid W, Elshal MF, Rovira II, et al. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi’s sarcoma. J Exp Med. 2006;203(5):1235–47. · DOI · Paper page
- Wang W, Zhong W, Yuan J, Yan C, Hu S, Tong Y, et al. Involvement of Wnt/β-catenin signaling in the mesenchymal stem cells promote metastatic growth and chemoresistance of cholangiocarcinoma. Oncotarget. 2015;6(39):42276–89. · DOI
Cited by
Sorted by citations
Stromal cells in the tumor microenvironment: accomplices of tumor progression?
Zhao, Y. F., Shen, M., Wu, L., Yang, H., Yao, Y., Yang, Q., Du, J., Liu, L., Li, Y., & Bai, Y. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06110-6 · Cited by 487
Emerging role of exosomes in cancer therapy: progress and challenges
Li, J., Wang, J., & Chen, Z. (2025) · Molecular Cancer · doi:10.1186/s12943-024-02215-4 · Cited by 297
Yu, L., Zhu, G., Zhang, Z., Yu, Y., Zeng, L., Xu, Z., Weng, J., Xia, J., Li, J., & Pathak, J. L. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01969-1 · Cited by 200
Cancer Resistance to Immunotherapy: Comprehensive Insights with Future Perspectives
Said, S. S., & Ibrahim, W. N. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041143 · Cited by 134
Hallmarks of cancer resistance
Tufail, M., Hu, J.-J., Liang, J., He, C., Wan, W., Huang, Y., Jiang, C., Wu, H., & Li, N. (2024) · iScience · doi:10.1016/j.isci.2024.109979 · Cited by 137
Metadata
- Authors
- Lan, T., Luo, M., & Wei, X.
- Affiliations
- Sichuan University (CN)
- Corresponding author
- Luo, Min
- Wei, Xiawei
- ORCID
- Venue
- Journal of Hematology & Oncology
- Published
- 2021-11-17
- Volume
- 14
- Issue
- 1
- Pages
- 195-195
- ISSN
- 1756-8722 (ISSN-L)
- PMC
- PMC8596342
- OpenAlex
- W3211554128
- Cited by
- 374
- References
- 205
- Citations by year
- 2026: 63 · 2025: 105 · 2024: 103 · 2023: 91 · 2022: 12
- FWCI
- 7.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Journal of Hematology & Oncology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation Regional Innovation and Development (U19A2003)
- National Major Scientific and Technological Special Project for “Significant New Drugs Development” (2018ZX09733001)
- Excellent Youth Foundation of the Sichuan Scientific Committee Grant in China (2019JDJQ008)
- Development Program of China (2016YFA0201402)
- National Natural Science Foundation of China (31800773)
- Sichuan Science and Technology Program (2019YJ0063)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Keywords
- mesenchymal stem cells, cancer therapy, cell therapy, immunomodulation, tumor homing, signaling pathways, clinical trials, translational medicine
- MeSH terms
- Translational Science, Biomedical, Animals, Humans, Neoplasms, Mesenchymal Stem Cell Transplantation, Immunomodulation, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
